1,3-dipropyl-8-cyclopentylxanthine has been researched along with ADDH in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, CB | 1 |
| Almeida, AS | 1 |
| Marques, DM | 1 |
| Faé, AHL | 1 |
| Machado, ACL | 1 |
| Oliveira, DL | 1 |
| Portela, LVC | 1 |
| Porciúncula, LO | 1 |
| Pires, VA | 1 |
| Pamplona, FA | 1 |
| Pandolfo, P | 1 |
| Fernandes, D | 1 |
| Prediger, RD | 1 |
| Takahashi, RN | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and ADDH
| Article | Year |
|---|---|
Caffeine and adenosine A
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Animals; Attention Deficit Disord | 2020 |
Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Attention Deficit Dis | 2009 |